Benjamin Halladay Sells 7,046 Shares of Esperion Therapeutics (NASDAQ:ESPR) Stock
MarketBeat
Esperion Therapeutics, Inc. (NASDAQ:ESPR - Get Free Report) CFO Benjamin Halladay sold 7,046 shares of the stock in a transaction on Wednesday, September 17th. The stock was sold at an average price of $2.81, for a total value of $19,799.26. Following the completion of the transaction, the chief financial officer directly owned 474,862 shares of the company's stock, valued at approximately $1,334,362.22. The trade was a 1.46% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.
NASDAQ:ESPR